Charith Perera1, Jack Wells1, Ian Harrison1, David Thomas2,3,4, and Mark Lythgoe1
1Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom, 2Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom, 3Leonard Wolfson Experimental Neurology Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom, 4Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
Synopsis
We employed an interleaved short/long echo-time ASL sequence
to better understand the differential response of vessels associated with the blood
brain barrier (BBB), and the relatively understudied blood-cerebrospinal fluid
barrier (BCSFB) to pharmacological perturbation in the healthy and aged brain. We
measured changes in both cortical perfusion and the BCSFB-ASL signal in
response CO2, caffeine, and vasopressin. Additionally, we
demonstrated a marked decrease in BCSFB reactivity towards vasopressin in the
aged vs adult brain. Together, these novel data highlight the value of this translational
approach to capture simultaneous and differential pharmacological modulation of
vessel tone at the BBB and BCSFB.
Introduction
The blood-brain-barrier (BBB) and blood-cerebrospinal
fluid barrier (BCSFB) mediate the complex interplay between blood and the brain.
Non-invasive CBF measurements obtained using arterial spin labelling (ASL) MRI
provide a surrogate measure of the functionality of the BBB to, for example,
facilitate a constant supply of oxygen and nutrients from the blood to the
highly metabolically active brain cells. We have recently developed an ASL-MRI
technique for the non-invasive assessment of BCSFB function: BCSFB-ASL uses an
ultra-long echo time to quantify the rate of BCSFB-mediated delivery of
endogenous arterial blood water to ventricular cerebrospinal fluid (CSF)1. Importantly, the technique allows repeated measures
with high temporal resolution which enables dynamic capture of the BCSFB’s
functional response to drugs for the first time.
By alternating the ultra-long and short TEs
used for BCSFB- and traditional-ASL, respectively, and keeping all other
parameters constant, we are able to
simultaneously capture two distinct physiological responses to a single drug dose
or ‘challenge’: i) parenchymal perfusion; ii) rates of BCSFB-mediated labelled arterial
blood water delivery to the CSF (a surrogate, non-invasive, measure of BCSFB
function). This approach provides an
efficient means to better understand the differential response of vessels associated
with the BBB and BCSFB to pharmacological perturbation in the healthy and
aged/diseased brain. Methods
We first applied the interleaved-TE ASL method in the
anaesthetized mouse brain (n=6) at 9.4T (Agilent), to investigate the effects
of several selected challenges on vessels perfusing the choroid plexus and the
cortex: vasopressin, CO2, and caffeine (further details: Table 1). The
interleaved-TE ASL protocol (Figure 3) utilized a FAIR-EPI labelling/readout
with parameters: TI = 4000ms, TR = 12000ms, TE = 20ms and 220ms for
traditional- and BCSFB-ASL, respectively, single 2.4mm slice centred on lateral
ventricles, matrix size: 32x32, FOV: 20mm x 20mm.
We investigated the mechanistic link between BCSFB
function and vasopressin in the aged brain by applying the interleaved-TE ASL
technique to capture the phMRI response to vasopressin in a cohort of aged
(23-months, n=14) and adult mice (5-months, n=14).
For each
subject, a single ROI drawn across the cortex/lateral ventricles provided the
mean average signal across the voxels for each slice-selective and
non-selective image pair. For each image pair, the slice-selective intensity (ML)
had its corresponding non-selective intensity (MC) subtracted to give
a ΔM value, which was then divided by its corresponding Mc. In a
subject-wise manner, ΔM/MC values were divided by the mean ΔM/MC value for the 10-minute baseline, providing a measure of relative,
baseline-normalised perfusion (short TE) and BCSFB-ASL signal (ultra-long TE
respectively).
Paired,
2-tailed t-tests were conducted when comparing challenge-responses to baseline.
Unpaired, 2-tailed t-tests were conducted to compare adult and aged cohorts.Results
Administration of saline vehicle revealed no significant changes in
cortical perfusion or the BCSFB-ASL signal. As expected, hypercapnia induced
increases in relative cortical perfusion (21%, p=0.0038, Figure 1 a-b). A
similar increase in the BCSFB-ASL signal from baseline was also observed (21%, p=0.031,
Figure 1c-d).
A marked vasopressin-induced decrease in the BCSFB-ASL signal was
observed (46%, p=0.0004, figures 1g-h). However, the 15% increase in cortical
perfusion only bordered significance (p=0.055, Figure 1e-f)
Caffeine stimulated significant decreases in the BCSFB-ASL signal (41% average,
p=0.0004, Figure
1k-l). Changes in cortical perfusion were not observed (p=0.25, Figure 1i- j).
Vasopressin induced a marked decrease in the BCSFB-ASL signal in the
adult cohort, averaging 27% (Figure 2a-b, p=0.00004). In
contrast, aged mice displayed an average 0.7% increase (n.s., p=0.93). This drastic impairment in the response of aged
mice vs their adult counterparts was statistically significant (p=0.013, Figure
2b).Discussion
Here we present a method to capture dynamic
responses of the BCSFB to pharmacological modulation. By employing an
interleaved-TE ASL sequence, we are also able to measure simultaneous dynamic
changes in cortical perfusion.
Dampened dilatory responses to CO2 have been implicated
in many pathological conditions affecting the brain microvasculature, such as cognitive decline in ageing and dementia2–5. Our
results indicate a significant, CO2-driven increase in CP perfusion
of a similar magnitude to that observed in the cortex.
Measurements
of caffeine-induced CBF changes in humans and rat models have shown CBF
decreases6,7. We provide dynamic data assessing the
immediate effects of caffeine in the mouse brain for the first time, observing marked decreases only in the BCSFB-ASL
signal.
It has become increasingly evident that the-BCSFB undergoes numerous morphological and
functional changes within the ageing brain8–10, with wide-ranging evidence that an increased levels of endogenous
vasopressin may underlie decline11–15. The observed impairment to a vasopressin challenge
observed in the aged brain highlights the potential for novel measurements of
BCSFB reactivity to provide upstream biomarkers of age-related pathological
processes. Conclusion
In
conclusion, our results illustrate the value of an interleaved-TE ASL MRI
approach to quantify pharmacologically-induced changes to vessels associated
with the BBB in the cortex and the BCSFB in the choroid plexus. The marked
impairment of the response to a vasopressin challenge within the aged mice highlight the capability of such
measurements to be utilised for probing altered functionality and
pathophysiology in the aged or diseased brain, providing a potential novel biomarker
of age-related cognitive decline. Acknowledgements
No acknowledgement found.References
1. Evans, P. G. et al.
Non-Invasive MRI of Blood–Cerebrospinal Fluid Barrier Function. Nat. Commun.
11, 1–11 (2020).
2. Zhou, Y., Rodgers, Z. B. & Kuo, A.
H. Cerebrovascular reactivity measured with arterial spin labeling and blood
oxygen level dependent techniques. Magn. Reson. Imaging 33, 566–576
(2015).
3. Suri, S. et al. Reduced
cerebrovascular reactivity in young adults carrying the APOE ε4 allele. Alzheimer’s
Dement. 11, 648-657.e1 (2015).
4. Hurford, R. et al. MRI-visible
perivascular spaces: Relationship to cognition and small vessel disease MRI
markers in ischaemic stroke and TIA. J. Neurol. Neurosurg. Psychiatry 85,
522–525 (2014).
5. Kastrup, A., Dichgans, J., Niemeier, M.
& Schabet, M. Changes of cerebrovascular CO2 reactivity during normal
aging. Stroke 29, 1311–1314 (1998).
6. Vidyasagar, R., Greyling, A., Draijer,
R., Corfield, D. R. & Parkes, L. M. The effect of black tea and caffeine on
regional cerebral blood flow measured with arterial spin labeling. J. Cereb.
Blood Flow Metab. 33, 963–968 (2013).
7. Nehlig, A., de Vasconcelos, A. P.,
Dumont, I. & Boyet, S. Effects of caffeine, L-phenylisopropyladenosine and
their combination on local cerebral blood flow in the rat. Eur. J.
Pharmacol. 179, 271–280 (1990).
8. Vandenbroucke, R. E. A hidden
epithelial barrier in the brain with a central role in regulating brain
homeostasis: Implications for aging. in Annals of the American Thoracic
Society vol. 13 S407–S410 (American Thoracic Society, 2016).
9. Balusu, S., Brkic, M., Libert, C. &
Vandenbroucke, R. E. The choroid plexus-cerebrospinal fluid interface in
Alzheimer’s disease: More than just a barrier. Neural Regeneration Research
vol. 11 534–537 (2016).
10. Serot, J. M., Foliguet, B., Béné, M. C.
& Faure, G. C. Choroid plexus and ageing in rats: A morphometric and
ultrastructural study. Eur. J. Neurosci. 14, 794–798 (2001).
11. Frolkis, V. V., Kvitnitskaya-Ryzhova, T.
Y. & Dubiley, T. A. Vasopressin, hypothalamo-neurohypophyseal system and
aging. Arch. Gerontol. Geriatr. 29, 193–214 (2000).
12. Liszczak, T. M., Foley, L. & Black,
P. M. L. Arginine vasopressin causes morphological changes suggestive of fluid
transport in rat choroid plexus epithelium. Cell Tissue Res. 246,
379–385 (1986).
13. Dohrmann, G. J. Dark and light epithelial
cells in the choroid plexus of mammals. J. Ultrasructure Res. 32,
268–273 (1970).
14. Johanson, C. E. et al. AVP V1
receptor-mediated decrease in Cl- efflux and increase in dark cell number in
choroid plexus epithelium. Am. J. Physiol. - Cell Physiol. 276,
(1999).
15. Sturrock, R. R. A morphological study of
the development of the mouse choroid plexus. J. Anat. 129, 777–93
(1979).